Guidance for the surveillance of drug resistance in TB

The World Health Organization (WHO) released the sixth edition of the Guidance for the surveillance of drug resistance in tuberculosis aiming to assist national TB programs in developing the strongest possible mechanisms of surveillance for drug resistance in TB, building on more than 25 years of global experience.

This starts from periodic surveys of sampled patients, moving towards an ultimate goal of continuous surveillance systems based on routine drug susceptibility testing. This guidance promotes certain standardized criteria for surveillance to ensure that results are comparable within and between countries over time.

The target audience of this document is national TB programs and, in particular, the coordination team for surveillance ideally composed of the program manager, a laboratory specialist, a logistician, and an epidemiologist/statistician.

To download the document, click here.

Source: WHO

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By World Health Organization

Published: April 19, 2021, 6:07 p.m.

Last updated: April 26, 2021, 5:11 p.m.

Print Share